FDA Approved: ARSENIC TRIOXIDE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for arsenic trioxide submitted by Fresenius Kabi USA, LLC under an existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

SUPPL AP for ARSENIC TRIOXIDE (ARSENIC TRIOXIDE)